FDA recall, , Low risk
American National Red Cross PF24 Plasma and Red Blood Cells
PF24 Plasma and Red Blood Cells, Leukocytes Reduced, with or without irradiation, were collected from donors whose arm inspections were not properly performed.
Recall ended Sep 8, 2026. Still check yours.
What happened
The American National Red Cross recalled Red Blood Cells, Leukocytes Reduced, Red Blood Cells, Leukocytes Reduced, Irradiated, and PF24 Plasma because they were collected from donors whose arm inspections were not properly performed. The recall began April 29, 2025, and involved products distributed in Indiana, Michigan and Ohio.
2 photos
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
3 products
Compare these details with yours, then check the recall notice to see which units are recalled.
Red Blood Cells, Leukocytes Reduced
Reason: Red Blood Cells, Leukocytes Reduced, collected from donors whose arm inspections were not properly performed, were distributed.
Red Blood Cells, Leukocytes Reduced, Irradiated
Reason: Red Blood Cells, Leukocytes Reduced, Irradiated, collected from donors whose arm inspections were not properly performed, were distributed.
PF24 Plasma
Reason: PF24 Plasma, collected from donors whose arm inspections were not properly performed, were distributed.
Recall details
- Company began the recall
- Company
- The American National Red Cross
- Hazard
- Blood donor screening
- Risk
Low risk
Taking it is unlikely to cause health problems.
FDA Class III recall · How risk is rated
- Event ID
- 99501
- Recall numbers
- B-0163-2026 to B-0165-2026
All recalls from The American National Red Cross
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary



